4ZFO: PDB entry 4ZFO
J22.9-xi: chimeric mouse/human antibody against human BCMA (CD269). Determined by X-ray diffraction at 1.9 Å resolution. Released 20 May 2015.
- Method
- X-ray diffraction
- Resolution
- 1.9 Å
- Organisms
- Homo sapiens, Mus musculus
- Chains
- 6
- Atoms
- 7,946
- Mol. weight
- 106.71 kDa
- Ligands
- CU, BTB
- Released
- 20 May 2015
Explore 4ZFO in 3D
Show helices and sheets
RCSB PDB
PDBe
Secondary structure: helices and β-sheets
4ZFO contains 41 α-helices and 90 β-strands across 6 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
Chain A: 10 helices, 21 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 17 |
| β-strand | 10-12 | 3 | 18 |
| β-strand | 18-25 | 8 | 17 |
| α-helix | 29-31 | 3 | |
| β-strand | 34-39 | 6 | 18 |
| β-strand | 45-51 | 7 | 18 |
| β-strand | 58-60 | 3 | 18 |
| α-helix | 62-64 | 3 | |
| β-strand | 68-73 | 6 | 17 |
| α-helix | 74-76 | 3 | |
| β-strand | 78-83 | 6 | 17 |
| α-helix | 88-90 | 3 | |
| β-strand | 92-102 | 11 | 18 |
| β-strand | 105-110 | 6 | 18 |
| β-strand | 114-118 | 5 | 18 |
| α-helix | 121-123 | 3 | |
| β-strand | 124 | 1 | 19 |
| α-helix | 125-126 | 2 | |
| β-strand | 127-131 | 5 | 20 |
| β-strand | 142-152 | 11 | 20 |
| β-strand | 153 | 1 | 19 |
| β-strand | 158-161 | 4 | 21 |
| α-helix | 162-164 | 3 | |
| β-strand | 170-172 | 3 | 20 |
| α-helix | 173-175 | 3 | |
| β-strand | 176-177 | 2 | 20 |
| β-strand | 183-192 | 10 | 20 |
| α-helix | 193-195 | 3 | |
| β-strand | 202-207 | 6 | 21 |
| α-helix | 208-210 | 3 | |
| β-strand | 212-217 | 6 | 21 |
Chain B: 9 helices, 21 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 4-5 | 2 | 12 |
| β-strand | 10-13 | 4 | 13 |
| β-strand | 19-25 | 7 | 12 |
| β-strand | 33-38 | 6 | 13 |
| β-strand | 45-49 | 5 | 13 |
| β-strand | 53-54 | 2 | 13 |
| α-helix | 55 | 1 | |
| β-strand | 62-66 | 5 | 12 |
| β-strand | 70-75 | 6 | 12 |
| α-helix | 80-82 | 3 | |
| β-strand | 85-90 | 6 | 13 |
| α-helix | 96 | 1 | |
| β-strand | 97-98 | 2 | 13 |
| β-strand | 102-106 | 5 | 13 |
| β-strand | 111 | 1 | 14 |
| α-helix | 112-113 | 2 | |
| β-strand | 114-118 | 5 | 15 |
| α-helix | 119-121 | 3 | |
| α-helix | 122-126 | 5 | |
| β-strand | 129-139 | 11 | 15 |
| β-strand | 140 | 1 | 14 |
| β-strand | 145-150 | 6 | 16 |
| β-strand | 153-154 | 2 | 16 |
| α-helix | 155 | 1 | |
| β-strand | 159-163 | 5 | 15 |
| α-helix | 164-167 | 4 | |
| β-strand | 173-182 | 10 | 15 |
| α-helix | 183-186 | 4 | |
| β-strand | 191-197 | 7 | 16 |
| β-strand | 205-210 | 6 | 16 |
Chains F and K: 2 helices, 2 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 12-15 | 4 | 1 |
| β-strand | 20-23 | 4 | 1 |
| α-helix | 24-27 | 4 | |
| α-helix | 35-37 | 3 | |
Chain H: 9 helices, 23 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 7 |
| β-strand | 10-12 | 3 | 8 |
| β-strand | 18-25 | 8 | 7 |
| β-strand | 34-39 | 6 | 8 |
| β-strand | 45-51 | 7 | 8 |
| β-strand | 58-60 | 3 | 8 |
| β-strand | 68-73 | 6 | 7 |
| α-helix | 74-76 | 3 | |
| β-strand | 78-83 | 6 | 7 |
| α-helix | 88-90 | 3 | |
| β-strand | 92-102 | 11 | 8 |
| β-strand | 105-110 | 6 | 8 |
| β-strand | 111 | 1 | 7 |
| β-strand | 114-118 | 5 | 8 |
| α-helix | 121-123 | 3 | |
| β-strand | 124 | 1 | 9 |
| α-helix | 125-126 | 2 | |
| β-strand | 127-131 | 5 | 10 |
| α-helix | 132-134 | 3 | |
| β-strand | 142-152 | 11 | 10 |
| β-strand | 153 | 1 | 9 |
| β-strand | 158-161 | 4 | 11 |
| α-helix | 162-164 | 3 | |
| β-strand | 166 | 1 | 11 |
| β-strand | 170-172 | 3 | 10 |
| α-helix | 173-175 | 3 | |
| β-strand | 176-177 | 2 | 10 |
| β-strand | 183-192 | 10 | 10 |
| α-helix | 193-195 | 3 | |
| β-strand | 202-207 | 6 | 11 |
| α-helix | 208-210 | 3 | |
| β-strand | 212-217 | 6 | 11 |
Chain L: 9 helices, 21 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 4-5 | 2 | 2 |
| β-strand | 10-13 | 4 | 3 |
| β-strand | 19-25 | 7 | 2 |
| β-strand | 33-38 | 6 | 3 |
| β-strand | 45-49 | 5 | 3 |
| β-strand | 53-54 | 2 | 3 |
| α-helix | 55 | 1 | |
| β-strand | 62-65 | 4 | 2 |
| β-strand | 70-75 | 6 | 2 |
| α-helix | 80-82 | 3 | |
| β-strand | 85-90 | 6 | 3 |
| α-helix | 96 | 1 | |
| β-strand | 97-98 | 2 | 3 |
| β-strand | 102-106 | 5 | 3 |
| β-strand | 111 | 1 | 4 |
| α-helix | 112-113 | 2 | |
| β-strand | 114-118 | 5 | 5 |
| α-helix | 119-121 | 3 | |
| α-helix | 122-125 | 4 | |
| β-strand | 129-139 | 11 | 5 |
| β-strand | 140 | 1 | 4 |
| β-strand | 145-150 | 6 | 6 |
| β-strand | 153-154 | 2 | 6 |
| α-helix | 155 | 1 | |
| β-strand | 159-163 | 5 | 5 |
| α-helix | 164-167 | 4 | |
| β-strand | 173-182 | 10 | 5 |
| α-helix | 183-186 | 4 | |
| β-strand | 191-197 | 7 | 6 |
| β-strand | 205-210 | 6 | 6 |
Molecules and chains
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|
| Tumor necrosis factor receptor superfamily member 17 | F, K | protein | 54 | Homo sapiens | Q02223 (AlphaFold model) |
| J22.9-xi Fab, Light Chain | L | protein | 214 | Mus musculus | |
| J22.9-xi Fab, Heavy Chain | A, H | protein | 221 | Mus musculus | |
| J22.9-xi Fab, Light Chain | B | protein | 213 | Mus musculus | |
Sequence of entity 1 (F, K), FASTA
>4ZFO_1 Tumor necrosis factor receptor superfamily member 17 (chains F, K)
MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNA
Sequence of entity 2 (L), FASTA
>4ZFO_2 J22.9-xi Fab, Light Chain (chains L)
DIVMTQSQRFMTTSVGDRVSVTCKASQSVDSNVAWYQQKPRQSPKALIFSASLRFSGVPA
RFTGSGSGTDFTLTISNLQSEDLAEYFCQQYNNYPLTFGAGTKLELKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEA
Sequence of entity 3 (A, H), FASTA
>4ZFO_3 J22.9-xi Fab, Heavy Chain (chains A, H)
QVQLQQSGGGLVQPGGSLKLSCAASGIDFSRYWMSWVRRAPGKGLEWIGEINPDSSTINY
APSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCASLYYDYGDAMDYWGQGTSVTVSS
ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPA
Sequence of entity 4 (B), FASTA
>4ZFO_4 J22.9-xi Fab, Light Chain (chains B)
DIVMTQSQRFMTTSVGDRVSVTCKASQSVDSNVAWYQQKPRQSPKALIFSASLRFSGVPA
RFTGSGSGTDFTLTISNLQSEDLAEYFCQQYNNYPLTFGAGTKLELKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE
Ligands and cofactors
| ID | Name | Formula | Copies |
|---|
| CU | Copper (II) ion | Cu | 3 |
| BTB | 2-[bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol | C8 H19 N O5 | 2 |
Primary citation
Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma. Oden, F., Marino, S.F., Brand, J. et al. Mol Oncol (2015) 9:1348-1358. DOI 10.1016/j.molonc.2015.03.010 · PubMed
Other PDB entries of the same protein (UniProt Q02223 (AlphaFold model), which also has an AlphaFold model), best resolution first:
- 1XU2 2.35 Å, The crystal structure of APRIL bound to BCMA
- 8HXQ 2.4 Å, Nanobody1 in complex with human BCMA ECD
- 1OQD 2.6 Å, Crystal structure of sTALL-1 and BCMA
- 6J7W 2.6 Å, Crystal Structure of Human BCMA in complex with UniAb(TM) VH
- 8HXR 2.7 Å, Nanobody2 in complex with human BCMA ECD
- 8QYA 2.72 Å, J22.9-FNY, fully humanized, CDR optimized Fab Fragment based on chimeric J22.9-xi IgG…
- 12ER 2.99 Å, Cryo-EM structure of BCMA in complex with the BCMA-targeted Fab arm of teclistamab and…
- 8QYB 3.09 Å, J22.9-ISY, fully humanized and CDR optimized Fab Fragment based on chimeric J22.9-xi IgG…
- 8QY9 3.1 Å, J22.9-H, fully humanized Fab Fragment based on chimeric J22.9-xi IgG against BCMA
- 9MQO 3.18 Å, Crystal structure of BCMA in complex with CA10v2 Fab
- 12ES 3.43 Å, Cryo-EM structure of BCMA in complex with the BCMA-targeted Fab arm of linvoseltamab and…
- 2KN1 Solution NMR Structure of BCMA
Browse structure collections
About this viewer
MolViewer shows 4ZFO directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.